RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+6.66%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$328M
AUM Growth
+$77.2M
(+31%)
Cap. Flow
+$74.7M
Cap. Flow
% of AUM
22.76%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
103
New
20
Increased
33
Reduced
37
Closed
13
Top Buys
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Gilead Sciences
GILD
|
$9.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.39M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.73M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.64M |
Top Sells
| 1 |
Innoviva
INVA
|
$4.71M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$3.73M |
| 3 |
Intuitive Surgical
ISRG
|
$3.07M |
| 4 |
Zimmer Biomet
ZBH
|
$2.8M |
| 5 |
AET
Aetna Inc
AET
|
$2.74M |
Sector Composition
| 1 | Healthcare | 80.94% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
51
DELISTED
St Jude Medical
STJ
| $2.25M | 0.68% |
34,394
-5,606
| -14% | -$367K |
|
52
Dynavax Technologies
DVAX
$1.2B
| $2.21M | 0.66% |
122,835
-17,165
| -12% | -$309K |
|
53
Nektar Therapeutics
NKTR
$635M
| $2.2M | 0.66% |
12,120
-547
| -4% | -$99.4K |
|
|
RAD
54
DELISTED
Rite Aid Corporation
RAD
| $2.16M | 0.65% |
+17,240
| New | +$2.16M |
|
|
OREX
55
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.14M | 0.64% |
32,920
+7,920
| +32% | +$515K |
|
56
Elevance Health
ELV
$70.5B
| $2.13M | 0.64% |
40,000
+8,000
| +25% | +$426K |
|
|
VAR
57
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.04M | 0.61% |
38,773
-1,140
| -3% | -$59.9K |
|
|
CPHD
58
DELISTED
Cepheid Inc
CPHD
| $2.03M | 0.61% |
39,308
+9,308
| +31% | +$480K |
|
59
Baxter International
BAX
$12.1B
| $1.98M | 0.6% |
77,633
+9,516
| +14% | +$243K |
|
|
ARIA
60
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.92M | 0.58% |
237,810
-462,190
| -66% | -$3.73M |
|
61
Johnson & Johnson
JNJ
$430B
| $1.91M | 0.57% |
19,481
-10,519
| -35% | -$1.03M |
|
|
HPTX
62
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.9M | 0.57% |
73,702
-36,298
| -33% | -$937K |
|
|
ITCI
63
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.79M | 0.54% |
+98,269
| New | +$1.79M |
|
64
Supernus Pharmaceuticals
SUPN
$2.52B
| $1.76M | 0.53% |
196,537
-28,463
| -13% | -$254K |
|
65
Masimo
MASI
$7.61B
| $1.74M | 0.52% |
+63,875
| New | +$1.74M |
|
|
AUXL
66
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $1.74M | 0.52% |
63,875
-21,125
| -25% | -$574K |
|
|
ECYT
67
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.64M | 0.49% |
68,788
+43,788
| +175% | +$1.04M |
|
68
Cencora
COR
$57.5B
| $1.64M | 0.49% |
35,000
-5,000
| -13% | -$234K |
|
69
Universal Health Services
UHS
$11.6B
| $1.61M | 0.48% |
+19,654
| New | +$1.61M |
|
70
Becton Dickinson
BDX
$54.5B
| $1.59M | 0.48% |
24,600
-1,025
| -4% | -$66.1K |
|
|
CFN
71
DELISTED
CAREFUSION CORPORATION
CFN
| $1.58M | 0.47% |
+39,308
| New | +$1.58M |
|
|
RVNC
72
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.55M | 0.46% |
+49,135
| New | +$1.55M |
|
|
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
| $1.55M | 0.46% |
329,199
-30,801
| -9% | -$145K |
|
74
Celldex Therapeutics
CLDX
$1.54B
| $1.3M | 0.39% |
4,913
-1,087
| -18% | -$288K |
|
75
Cardiff Oncology
CRDF
$136M
| $1.13M | 0.34% |
2,730
-48
| -2% | -$19.8K |
|